Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Achieving Sustainable Global Capacity for Surveillance and ...
Released: December 22, 2008
One of the biggest threats today is the uncertainty surrounding the emergence of a novel pathogen or the re-emergence of a known infectious disease that might result in disease outbreaks with great losses of human life and immense global economic consequences. In June 2008, the Institute of Medicine’s and National Research Council’s Committee on Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin convened a workshop that addressed the reasons for the transmission of zoonotic disease and explored the current global capacity for zoonotic disease surveillance.
The US Commitment to Global Health: Recommendations for ...
Released: December 09, 2008
At this historic moment, the incoming Obama administration and leaders of the U.S. Congress have the opportunity to advance the welfare and prosperity of people within and beyond the borders of the United States through intensified and sustained attention to better health. The Institute of Medicine—with the support of four U.S. government agencies and five private foundations—formed an independent committee to examine the United States’ commitment to global health and to articulate a vision for future U.S. investments and activities in this area.
Global Climate Change and Extreme Weather Events. ...
Released: September 24, 2008
On December 4 and 5, 2007, the Forum on Microbial Threats hosted a public workshop in Washington, DC to consider the possible infectious disease impacts of global climate change and extreme weather events on human, animal, and plant health, as well as their expected implications for global and national security.
Design Considerations for Evaluating the Impact of PEPFAR. ...
Released: September 15, 2008
Design Considerations for Evaluating the Impact of PEPFAR is the summary of a 2-day workshop on methodological, policy, and practical design considerations for a future evaluation of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) interventions carried out under the President’s Emergency Plan for AIDS Relief (PEPFAR), which was convened by the Institute of Medicine (IOM) on April 30 and May 1, 2007.
Assessment of the Role of Intermittent Preventive Treatment ...
Released: July 10, 2008
The Bill and Melinda Gates Foundation requested that the Institute of Medicine (IOM) conduct an independent assessment of the IPTi efficacy studies using sulfadoxine-pyrimethamine (IPTi-SP) that have been previously conducted by the IPTi Consortium. The IOM convened a committee to evaluate the evidence concerning IPTi-SP, which included addressing issues related to its utility and safety, as well as program management aspects of IPTi. The resulting letter report contains the findings, conclusions, and recommendations of the IOM committee.
Vector-Borne Diseases: Understanding the Environmental ...
Released: March 18, 2008
The Institute of Medicine’s Forum on Microbial Threats convened a workshop—on June 19-20, 2007, in Ft. Collins, CO—entitled Vector-Borne Diseases: Understanding the Environmental, Human Health, and Ecological Connections. The purpose of this public workshop was to examine the global burden of vector-borne diseases of humans, animals, and plants, and to discuss prospects for successful mitigation and response strategies.
Methodological Challenges in Biomedical HIV Prevention ...
Released: February 21, 2008
A new Institute of Medicine report, Methodological Challenges in Biomedical HIV Prevention Trials, discusses various ways to improve the design, monitoring, and analysis of late-stage randomized clinical trials of biomedical interventions to prevent HIV infection. The main goals are to increase the chances that these trials will detect a beneficial effect on HIV infection risk and to more fully assess how adherence to the intervention influences HIV infection risk, and to assess the intervention’s effect on HIV risk behavior.
Violence Prevention in Low- and Middle-Income Countries ...
Released: January 25, 2008
The current state of science in violence prevention reveals progress, promise, and a number of remaining challenges. In order to fully examine the issue of global violence prevention, the Institute of Medicine in collaboration with Global Violence Prevention Advocacy, convened a workshop and released the workshop summary entitled, Violence Prevention in Low-and Middle-Income Countries.
Global Infectious Disease Surveillance and Detection ...
Released: October 22, 2007
The Institute of Medicine’s (IOM’s) Forum on Microbial Threats convened a workshop addressing Global Infectious Disease Surveillance and Detection: Assessing the Challenges—Finding Solutions on December 12 and 13, 2006, to consider scientific and policy issues relevant to the practice of disease surveillance and detection.
Review of the DoD-GEIS Influenza Programs: Strengthening ...
Released: September 25, 2007
In 2006, spurred in part by concerns about the H5N1 virus, Congress allocated $39 million in supplemental funding for DoD-GEIS to improve this surveillance network by upgrading the capabilities of its domestic and overseas laboratories. Afterward, DoD-GEIS management asked the Institute of Medicine to form a committee that would evaluate how well DoD-GEIS had spent the supplemental funds.